Skip to main content

Percent of TB Financing Received from Domestic Sources

References in the content below refer to the PBMEF Guide.

Definitions

Percent of National TB Program (NTP’s) budget received from domestic sources during the reporting period.

Calculation: (Numerator/Denominator) x 100

Numerator

The amount of NTP’s budget received from domestic sources (including loans) during the reporting period (in U.S. dollars).

Denominator

The amount of NTP’s budget received from all sources (domestic, the Global Fund to Fight AIDS, Tuberculosis and Malaria, USAID, and other sources) during the reporting period (in U.S. Dollars).
Ref #
SN_DOMESTICR
(Previously SN-1)
Tier Level
Core Indicator
Category
Sustain
Type
Core Outcome
Unit of Measure
Percent of funding
Data Type
Percentage
Disaggregations
N/A
Reporting Level
All Core PBMEF indicators should be reported at the national level.
Reporting Frequency
Annual. Performance plans and reports (PPR) for this indicator are based on calendar year (CY) periodicity to reflect national level attainment and align with the USAID congressional reporting requirements.

NTPs report this indicator on an annual basis to the World Health Organization (WHO); where missions are not able to get a direct value from the NTP, the value included in the most recent WHO Global TB Report should be used for reporting purposes.

The WHO indicator for the numerator is rcvd_tot_domestic (funding received from domestic sources, including loans [US dollars]), and the denominator is rcvd_tot_sources (total funding received from all sources [US dollars]).

A key measurement of a country’s sustainability of resources is how it implements its national strategic plan (NSP). While international donor funding is still critical for low- and middle-income countries, increasing the share of funding from domestic sources is necessary for sustainability. This indicator measures the amount of funding that is expected to be mobilized from domestic sources out of all available sources. It is a good planning tool for the country to gauge how much it can and should plan to mobilize in the next budget cycle to reduce the level of dependency on international donors.

According to the 2022 WHO Global TB Report, most of the USD$5.4 billion available in 2021 is from domestic sources (79% of the total). However, the high volume of funding in the BRICS group of countries (Brazil, the Russian Federation, India, China, and South Africa) influences this figure. In other low- and middle-income countries, international donor funding remains crucial. This indicator is also a measure of a national government’s level of financial commitment to TB.

Percentage of received domestic financing for TB can be analyzed as a trend over time either on its own or against country and/or global targets, such as the total budget required to fund a NSP. Indeed, a comparison between the total budget required (budget_tot) versus the amount received (rcvd_tot_sources) will give a picture of the budget shortfall that the NTP faces, and therefore help in deciding domestic resource mobilization to meet those shortfalls.

Further, received funds can be compared to budgeted or expected funds to highlight gaps in utilization of domestic funding either within a given year or budget cycle, or as a trend over time. Thus, analyzing the general trend of funding received from domestic sources, including loans (U.S. dollars) [rcvd_tot_domestic] as a percentage of expected funding from domestic sources, including loans (U.S. dollars) [cf_tot_domestic] can help to understand the chronic deficiency the country is facing in fulfilling its budgetary commitment to NTP. This could be reviewed in the context of overall budget shortfall/over-budgeting by comparing total funding received for all budget line items (U.S. dollars) [rcvd_tot] versus total budget required (U.S. dollars) [budget_tot].

There are no related indicators for this indicator.

Indicator Visualizations

Changelog

January, 2024: Updated the name, definition, and other information based on the Interim PBMEF Tuberculosis Indicator Compendium.